Using AI/ML for Identification and Optimization of Therapeutic Molecules
Wednesday, June 05, 2024
Breakout Session
![AI and Digital Health](https://cdn.asp.events/CLIENT_BIO_7BB99CBA_BAD1_B8C8_CF9F25DA29A80CC6/sites/BIOIC-2024/media/icons/seminars/digitalhealth.png)
30ABC
Increased investment and rapid development of AI/ML tools for hit identification, multiparameter optimization, and in vivo property prediction are currently accelerating drug discovery in small molecules. Simultaneously, a rapid advancement in the field of de novo design in large molecule therapeutics is occurring. Despite these advances, delivering broad pipeline impact across a diverse target space continues to be a challenge. This panel will discuss opportunities and challenges, and approaches to unlock the potential burgeoning potential of AI/ML in drug discovery.
Moderator
Speakers
![](https://www.conferenceharvester.com/uploads/harvester/photos/XDQDGWMO-Presenter-ScheerJ.jpg)
Vice President, Global Head, In Silico Discovery
Johnson & Johnson Innovative Medicine
Sponsored by:
![johnson and johnson](https://cdn.asp.events/CLIENT_BIO_7BB99CBA_BAD1_B8C8_CF9F25DA29A80CC6/sites/BIOIC-2024/media/libraries/sponsors-example/JJ_Logo_SingleLine_Red_RGB.png)